These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [level of 7alpha-hydroxycholesterol in blood plasma as an indicator of cholesterol catabolism in hyperlipidemia and with hypolipidemic therapy]. Poliakova ED, Ivanova TN, Voshchinnikov EI, Olfer'ev AM, Perova NV. Vopr Med Khim; 2000 Apr; 46(2):168-75. PubMed ID: 10885038 [Abstract] [Full Text] [Related]
16. Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia. Arca M, Montali A, Pigna G, Antonini R, Antonini TM, Luigi P, Fraioli A, Mastrantoni M, Maddaloni M, Letizia C. Metabolism; 2007 Nov 29; 56(11):1534-41. PubMed ID: 17950105 [Abstract] [Full Text] [Related]
19. [Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip]. Scherhag R. Fortschr Med; 1983 Sep 22; 101(36):1635-7. PubMed ID: 6629296 [Abstract] [Full Text] [Related]
20. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia]. Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T. Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]